Semnur Pharmaceuticals has initiated a Phase 3 study for the treatment of lumbar radicular pain, commonly known as sciatica and has been granted fast track designation by the FDA.
semnur on the fast track
Semnur Pharmaceuticals has initiated a Phase 3 study for the treatment of lumbar radicular pain, commonly known as sciatica and has been granted fast track designation by the FDA.